Kuala lumpur: SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ('SBC Medical' or the 'Company'), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced a strategic Consulting Agreement with BLEZ ASIA Co., Ltd. (Headquarters: Bangkok, Thailand; CEO: Naoki Iida; 'BLEZ'). BLEZ operates more than 20 pharmacies and clinics in Thailand and is widely trusted by both Japanese expatriates and local patients. This partnership is a key element of SBC's broader strategy in Asia, marking a significant step toward entering the rapidly expanding Thai aesthetic medicine market.

According to BERNAMA News Agency, under the agreement, SBC will provide comprehensive management support to a new clinic in Bangkok, primarily focused on dermatological treatments such as pigmentation and spot removal. BLEZ is preparing to open this clinic, and SBC will advise on clinical protocol development aligned with its quality standards. Additionally, SBC will assist in selecting medical devices and treatment methods optimized for local skin characteristics and environmental conditions. The clinic is expected to commence operations by year-end in the Asok district of Bangkok.

SBC operates a network of over 250 clinics worldwide, welcoming more than 6 million patient visits annually. By combining SBC's expertise in delivering high-quality and safe aesthetic medical services developed in Japan with BLEZ's trusted local presence, the two companies aim to establish a solid foothold among Japanese expatriates in Thailand. Following validation of service demand and operational performance, SBC and BLEZ intend to expand patient acquisition to the broader Thai market and pursue incremental growth opportunities across ASEAN.